Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/20/2012 | US20120321651 Anti-IGE Vaccines |
12/20/2012 | US20120321649 Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens |
12/20/2012 | US20120321643 Anti-epidermal growth factor receptor antibodies and uses thereof |
12/20/2012 | US20120321636 Antibodies specific for sclerostin and methods for increasing bone mineralization |
12/20/2012 | US20120321634 Estrogen receptors and methods of use |
12/20/2012 | US20120321633 Anti-human epo receptor antibodies and methods of use |
12/20/2012 | US20120321629 Stem cell factor inhibitor |
12/20/2012 | US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof |
12/20/2012 | US20120321626 Multi-specific fab fusion proteins and methods of use |
12/20/2012 | US20120321623 ILT3 Polypeptides and Uses Thereof |
12/20/2012 | US20120321621 INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS |
12/20/2012 | US20120321619 Anti-c4.4a antibodies and uses thereof |
12/20/2012 | US20120321618 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle) |
12/20/2012 | US20120321617 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle) |
12/20/2012 | US20120321614 Antibodies to c-met |
12/20/2012 | US20120321608 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
12/20/2012 | US20120321607 Factor VII Fusion Polypeptides |
12/20/2012 | US20120321601 Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase Inhibitor |
12/20/2012 | US20120321598 Vectors and methods for long-term immune evasion to prolong tranplant viability |
12/20/2012 | US20120321594 Methods of controlling axon or dendrite development of neuronal cells |
12/20/2012 | US20120321593 Low oxygen culture conditions for maintaining retinal progenitor cell multipotency |
12/20/2012 | US20120321589 Antibody Fusion Proteins with Disrupted Heparin-Binding Activity |
12/20/2012 | US20120321573 Compositions and methods of prophylaxis for contact dermatitis |
12/20/2012 | US20120321562 Nicotinic acid and picolinic acid derived near-infrared fluorophores |
12/20/2012 | CA2839589A1 Methods of treating retroviral infections in felines |
12/20/2012 | CA2806625A1 Isolated embryonic stem cells that express lineage markers and associated methods |
12/19/2012 | EP2535404A1 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera |
12/19/2012 | EP2535403A1 Very small embryonic-like (VSEL) stem cells and methods of isolating and using the same |
12/19/2012 | EP2535355A2 Antibodies against CD38 for treatment of multiple myeloma |
12/19/2012 | EP2535052A1 Method for producing nk cell enhancement-type blood product |
12/19/2012 | EP2534242A1 Improved composition for inhibiting tumor cell proliferation |
12/19/2012 | EP2533882A1 Zeolite membrane for cellular adhesion, growth and cultures and process for preparation thereof |
12/19/2012 | CN1720323B 细胞培养 Cell Culture |
12/19/2012 | CN1636229B Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response |
12/19/2012 | CN102834524A Manufacturing method for 5-(aminomethyl)-2-chlorothiazole |
12/19/2012 | CN102834517A Polynucleotides encoding nf-yb originating in jatropha and utilization thereof |
12/19/2012 | CN102834516A L-threonine analysis method and l-threonine dehydrogenase |
12/19/2012 | CN102834506A Method for producing regulatory dendritic cells |
12/19/2012 | CN102834505A Composition and method for differentiation of human embryonic stem cells |
12/19/2012 | CN102834503A A Continuous Culturing Device |
12/19/2012 | CN102833997A Control of AAD dicot volunteers in monocot crops |
12/19/2012 | CN102830053A Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
12/19/2012 | CN102827880A Method for biologically synthesizing fatty alcohol from fatty acyl ACP (acyl carrier protein) reductase |
12/19/2012 | CN102827873A Cre fusion protein functional test cell and modified Cre fusion protein |
12/19/2012 | CN102827872A Establishment of pitressin V1 receptor stable expression cell line and its application in drug screening |
12/19/2012 | CN102827871A Establishment of P2Y1 stable expression cell line and its application in drug screening |
12/19/2012 | CN102827870A Establishment of ET1 stable expression cell line and its application in drug screening |
12/19/2012 | CN102827869A Establishment of P2Y122 stable expression cell line and its application in drug screening |
12/19/2012 | CN102827868A Establishment of pitressin V2 receptor stable expression cell line and its application in drug screening |
12/19/2012 | CN102827867A Establishment of ET2 stable expression cell line and its application in drug screening |
12/19/2012 | CN102827865A Plants having increased yield-related traits and a method for making the same |
12/19/2012 | CN102827855A Nucleotide sequence of food-grade L-arabinose isomerase derived from Pediococcus pentosaceus, and application of food-grade L-arabinose isomerase |
12/19/2012 | CN102827846A Preparation method and application of recombination coxsackie virus B3-type virus-like particles |
12/19/2012 | CN102827815A A group of cyclodextrin glucosyltransferase, and coding gene and application thereof |
12/19/2012 | CN102827813A Anti-human CD133 monoclonal antibody and preparation method and applications thereof |
12/19/2012 | CN102827812A Preparation method and application of induction type neural stem cells |
12/19/2012 | CN102827811A Human breast cancer chronic intermittent hypoxia cell line, and preparation method thereof |
12/19/2012 | CN102827810A Non-animal-source serum-free culture medium for umbilical cord blood stem cells |
12/19/2012 | CN102827809A Preparation method of CIK (Cytokine Induced Killer) cells with high proliferation capacity, high cytotoxic activity and high survival rate, associated CIK cells and application |
12/19/2012 | CN102827808A Method for preparing cytokine-induced killer cells |
12/19/2012 | CN102827807A Serum-free culture medium for mesenchymal stem cells |
12/19/2012 | CN102827806A Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
12/19/2012 | CN102827805A HUVEC (human umbilical vein endothelial cell) separation, culture and subculture method |
12/19/2012 | CN102827804A Culture medium applicable to suspension and magnification cultivation of Vero cell microcarriers and method for suspension magnification cultivation of Vero cell microcarriers |
12/19/2012 | CN102827803A Preparation method of silkworm decellularization hemolymph liquid |
12/19/2012 | CN102827772A Culture medium pouring method and device |
12/19/2012 | CN102827287A Compositions and methods for diagnosing and treating cancer |
12/19/2012 | CN102827283A Transgenic non-human animals capable of producing heterologous antibodies |
12/19/2012 | CN102827281A Monoclonal antibody against CD2 protein and application thereof |
12/19/2012 | CN102827280A Anti-IL-13 antibodies and use thereof |
12/19/2012 | CN102827278A Antitumor protein P53 monoclonal antibody and application thereof |
12/19/2012 | CN102827267A Humanized pika leptin protein, gene coding same and application thereof |
12/19/2012 | CN102827265A Novel gene of sorting nexin (SNX) family and use thereof |
12/19/2012 | CN102827262A OsMIOX protein and coding gene and drought defying application thereof |
12/19/2012 | CN102329795B Cucumber violaxanthin decyclization oxidase gene promoter and application thereof |
12/19/2012 | CN102321569B Method for constructing Kareius bicoloratus liver cell line |
12/19/2012 | CN102286429B Sarcomatoid renal cell carcinoma cell line from people of Han nationality and preparation method thereof |
12/19/2012 | CN102268433B Plant aging specific promoter and application thereof |
12/19/2012 | CN102250894B Specific expression promoter for plant embryo and application thereof |
12/19/2012 | CN102234630B Tumor engineering cells for screening reversible gene silencing drugs and application thereof |
12/19/2012 | CN102212504B Rabbit intestinal epithelial cell line and preparation method thereof |
12/19/2012 | CN102154347B Method for reducing expression level of PPO (polyphenol oxidase) and PSY (phytoene synthase) genes and special RNAi (RNA interference) vector thereof |
12/19/2012 | CN102154206B Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell |
12/19/2012 | CN102093981B Method for efficiently inducing reprogramming of human body cells into pluripotent stem cells |
12/19/2012 | CN102086438B Device and method for biological culture of cell or tissue engineering |
12/19/2012 | CN102021175B Optimized grass carp alpha interferon encoding gene and application thereof |
12/19/2012 | CN102002097B Mutant protein capable of being combined with nisin, and coded gene and application thereof |
12/19/2012 | CN101948796B Method for extracting orange flesh chromoplast |
12/19/2012 | CN101921778B Gene DvCRP1 with Cd<2+> and Cu<2+> resistance as well as coding protein and application thereof |
12/19/2012 | CN101914534B Seedling and seed specific expression GmPLPA gene promoter for soybean and application thereof |
12/19/2012 | CN101760452B Heterozygous cell line of embryonic stem cell and tumour cell and construction method thereof |
12/19/2012 | CN101679968B Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof |
12/19/2012 | CN101441222B Method for detecting Beta accompany glycinin and specific antibody and reagent kit thereof |
12/19/2012 | CN101437540B Melanocortin receptor binding mimetibodies, compositions, methods and uses |
12/19/2012 | CA2792025A1 Soybean cultivar ow1012932 |
12/18/2012 | US8334445 Maize variety hybrid 10967280 |
12/18/2012 | US8334438 Soybean cultivar 8919112 |
12/18/2012 | US8334436 Soybean cultivar 93454905 |
12/18/2012 | US8334430 Methods for producing hybrid seed |
12/18/2012 | US8334374 Methods and means for obtaining modified phenotypes |